These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 9467939

  • 1. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
    Eiriksdottir G, Barkardottir RB, Agnarsson BA, Johannesdottir G, Olafsdottir K, Egilsson V, Ingvarsson S.
    Oncogene; 1998 Jan 08; 16(1):21-6. PubMed ID: 9467939
    [Abstract] [Full Text] [Related]

  • 2. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P.
    Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152
    [Abstract] [Full Text] [Related]

  • 3. High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutation.
    Ingvarsson S, Geirsdottir EK, Johannesdottir G, Sigbjörnsdóttir BI, Eiriksdottir G, Ragnarsson G, Agnarsson BA, Gudmundsson J, Jonasson JG, Sigurdsson A, Egilsson V, Barkardottir RB.
    Cancer Res; 1998 Oct 01; 58(19):4421-5. PubMed ID: 9766673
    [Abstract] [Full Text] [Related]

  • 4. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer.
    Tseng SL, Yu IC, Yue CT, Chang SF, Chang TM, Wu CW, Shen CY.
    Genes Chromosomes Cancer; 1997 Dec 01; 20(4):377-82. PubMed ID: 9408754
    [Abstract] [Full Text] [Related]

  • 5. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
    Armes JE, Trute L, White D, Southey MC, Hammet F, Tesoriero A, Hutchins AM, Dite GS, McCredie MR, Giles GG, Hopper JL, Venter DJ.
    Cancer Res; 1999 Apr 15; 59(8):2011-7. PubMed ID: 10213514
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S, Poppe K, Fischer J, Nothnagel A, Estévez-Schwarz L, Haensch W, Schlag PM, Scherneck S.
    J Pathol; 2001 Jul 15; 194(3):318-26. PubMed ID: 11439364
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A region close to Tp53 shows LOH in familial breast cancer.
    Luo L, Chen J, Du Q, Dumanski J, Blennow E, Kockum I, Luthman H, Lindblom A.
    Int J Mol Med; 2002 Apr 15; 9(4):405-9. PubMed ID: 11891537
    [Abstract] [Full Text] [Related]

  • 10. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R, Groussin L, Tissier F, Elie C, René-Corail F, Fratticci A, Jullian E, Beck-Peccoz P, Bertagna X, Gicquel C, Bertherat J.
    Clin Cancer Res; 2007 Feb 01; 13(3):844-50. PubMed ID: 17289876
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. BRCA2 mutations in primary breast and ovarian cancers.
    Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR, Futreal PA.
    Nat Genet; 1996 Jun 01; 13(2):238-40. PubMed ID: 8640235
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA, Zhuang Z, Man Y, Park WS, Emmert-Buck M, Tavassoli FA.
    Mod Pathol; 1999 Dec 01; 12(12):1083-9. PubMed ID: 10619258
    [Abstract] [Full Text] [Related]

  • 16. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN, Presneau N, Provencher D, Mes-Masson AM, Tonin PN.
    Mol Carcinog; 2002 Jun 01; 34(2):78-90. PubMed ID: 12112314
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H, Joosse SA, van Oostrom CT, Nederlof PM, de Vries A, Jonkers J.
    Cancer Res; 2009 Apr 15; 69(8):3625-33. PubMed ID: 19336573
    [Abstract] [Full Text] [Related]

  • 19. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
    Sigbjörnsdottir BI, Ragnarsson G, Agnarsson BA, Huiping C, Barkardottir RB, Egilsson V, Ingvarsson S.
    J Med Genet; 2000 May 15; 37(5):342-7. PubMed ID: 10807692
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.